DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Parenteral Nutrition Light Protection and Premature Outcomes

Not Applicable

Completed

Conditions: Premature Birth

Interventions: Other: Full parenteral nutrition light protection of the bag, tubing and lipids

First Posted Date: 2020-08-25

Last Posted Date: 2022-11-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 36

Registration Number: NCT04525872

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery

Phase 4

Completed

Conditions: Pain, Postoperative
Spine Injuries and Disorders
Narcotic Use

Interventions: Drug: Pre-op Multimodal analgesia (MMA) regimen + standard post-op oxycodone

First Posted Date: 2020-08-21

Last Posted Date: 2022-07-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 44

Registration Number: NCT04522206

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Pilot Randomized-controlled Trial of Integrated Palliative and Nephrology Care Versus Usual Nephrology Care.

Early Phase 1

Completed

Conditions: Chronic Kidney Diseases

Interventions: Other: Integrated ambulatory palliative and nephrology care
Other: Standard nephrology care

First Posted Date: 2020-08-20

Last Posted Date: 2021-10-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 45

Registration Number: NCT04520984

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

Completed

Conditions: Covid19
Acute Respiratory Distress Syndrome
Bacterial Sepsis
Bacterial Infections

Interventions: Device: BVA-100
Device: Transpulmonary Thermodilution (TPTD)
Device: Sublingual Microcirculation

First Posted Date: 2020-08-18

Last Posted Date: 2023-09-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 39

Registration Number: NCT04517695

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States

Integrating the Quit and Stay Quit Monday Model Into Smoking Cessation Services for Smokers With Mental Health Conditions

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Quit and Stay Quit Monday Model

First Posted Date: 2020-08-13

Last Posted Date: 2022-01-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 70

Registration Number: NCT04512248

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Evolocumab In Advanced Chronic Kidney Disease Trial

Phase 4

Withdrawn

Conditions: Chronic Kidney Diseases
High Cholesterol

Interventions: Other: Placebo
Drug: Evolocumab

First Posted Date: 2020-08-12

Last Posted Date: 2022-07-28

Lead Sponsor: NYU Langone Health

Registration Number: NCT04510844

Locations: 🇺🇸
NYU Langone Nephrology Associates - Long Island, Mineola, New York, United States
🇺🇸
NYU Langone Health, New York, New York, United States

A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT

Not Applicable

Completed

Conditions: Hematologic Malignancy

Interventions: Radiation: Linac Based VMAT TBI

First Posted Date: 2020-08-12

Last Posted Date: 2025-04-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 35

Registration Number: NCT04509765

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

Phase 1

Completed

Conditions: Graft-versus-host Disease

Interventions: Drug: Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

First Posted Date: 2020-08-07

Last Posted Date: 2024-10-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 46

Registration Number: NCT04503616

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Adherence Connection for Counseling, Education, and Support (ACCESS) II

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Behavioral: ACCESS II mHealth Intervention
Behavioral: ACCESS II control condition

First Posted Date: 2020-08-05

Last Posted Date: 2025-01-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT04499781

Locations: 🇺🇸
Jacobi Medical Center, Bronx, New York, United States

Feasibility Open Label Study Evaluating The Use Of Process-Instructed Self Neuro-Modulation (PRISM) For Post-Traumatic Stress Disorder

Not Applicable

Withdrawn

Conditions: Post-traumatic Stress Disorder

Interventions: Device: PROCESS-INSTRUCTED SELF NEURO-MODULATION (PRISM)

First Posted Date: 2020-08-03

Last Posted Date: 2021-06-14

Lead Sponsor: NYU Langone Health

Registration Number: NCT04496557

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy